Cancer Weekly articles from March 1993

Cancer Weekly archives from March 1993

Cigarette smoking may raise risk of leukemia. (Missouri)
March 1, 1993... Cigarette smoking may raise a person's risk of leukemia by 30 percent and cause about 14 percent of the nation's adult leukemia cases, scientists reported. That would mean perhaps 3,600 cases a year, said researchers who pooled results...

Surgeon cautions fat injections for breast enlargement pose health threat. (Dr. Kirby Bland) (University of Florida)
March 1, 1993... Using fat injections to enlarge breasts can be dangerous for women who are at high risk for breast cancer, have had surgery for breast cancer or have a premalignant condition, says Dr. Kirby Bland, professor and associate chairman of surgery at...

Contraceptive protects against reproductive cancers, analysis shows. (University of South Carolina)
March 1, 1993... Even if the birth control pills do increase the risk for breast cancer, oral contraceptive use would reduce the overall incidence of reproductive cancer in women, a new study concluded. Overall, among every 100,000 women who used birth...

Center awarded $3 million to study breast cancer and electromagnetic radiation. (Fred Hutchinson Cancer Research Center)
March 1, 1993... The Fred Hutchinson Cancer Research Center, Seattle, Washington, in collaboration with Battelle Pacific Northwest Laboratories, was recentlyy awarded a $3 million grant from the U.S. National Cancer Institute (NCI) to investigate the...

Doctor calls for more research on cellular phones. (Dr. John Nash Ott) (Florida)
March 1, 1993... The cellular phone scare has recently attested to a basic scientific premise that Dr. John Nash Ott has been asserting for more than 40 years. The best safe level for any radiation is no level. While the industry indicates that it will...

Cancer study determines accurate heat treatment dose. (Duke Comprehensive Cancer Center)
March 1, 1993... Researchers at Duke Comprehensive Cancer Center, Durham, North Carolina, have developed techniques to improve the effectiveness of heat with radiation or drugs to treat cancer. The scientists said they have formulated a way to better...

"Freezing" prostate could eliminate cancer surgery. (Rush-Presbyterian-St. Luke's Medical Center)
March 1, 1993... Urologists at Rush-Presbyterian-St. Luke's Medical Center in Chicago, Illinois, are investigating the effectiveness of cryosurgery - a technique which "freezes" cells - for men with prostate cancer. While the long-term effects of...

Double bone-marrow transplant may curb cancer growth. (Rush-Presbyterian-St. Luke's Medical Center)
March 1, 1993... The high dose of chemotherapy required to kill some tumors destroys the patient's ability to make new blood cells. For some patients, one course of this treatment may not be enough. A bone-marrow transplant can restore that ability. Now,...

Researchers to study effect of vitamin D in cancer patients. (prostate cancer) (University of Pittsburgh)
March 1, 1993... Vitamin D could illuminate the path to a treatment for prostate cancer, said researchers who will give the vitamin to a test group of patients. Doctors at the University of Pittsburgh plan to recruit men in advanced states of prostate...

Bill to require insurance firms to cover cancer treatment pending. (Colorado)
March 1, 1993... Health insurers would be required to pay for "clinical trial" cancer treatmen under a bill pending in a Colorado State Senate committee. "Health insurance is insurance for ill health - not for what [the insurers] decide is the best...

Child cancer patients develop game about disease. (Road to Remission) (Ohio)
March 1, 1993... A group of children with cancer spent some of their time between chemotherapy treatments inventing a game to help them deal with the disease. Two years later, "Road to Remission" is being marketed to children's hospitalsacross the country,...

Immunomedics reports promising preclinical results of lymphoma therapeutic. (LL2 monoclonal antibody) (New Jersey)
March 1, 1993... Immunomedics Inc., Morris Plains, New Jersey, announced that preclinical studies at the U.S. National Cancer Institute (NCI) demonstrated significant antitumor activity of the Company's proprietary monoclonal antibody (MAb), known as LL2, for...

Company announces Phase III trial of Oncolysin B to begin. (ImmunoGen Inc.)
March 1, 1993... ImmunoGen Inc., Cambridge, Massachusetts, announced that the company will begin a Phase III trial of its lead product, Oncolysin B, soon after the signing of an agreement with a nationally recognized oncology group. Contract negotiations...

FDA marketing clearance for rapid fecal occult blood test filed. (QuickVue One-Step Fecal Occult Blood Test) (Quidel Corporation)
March 1, 1993... Quidel Corporation, San Diego, California, said it has filed a 510(k) submission with the U.S. Food and Drug Administration (FDA) for clearance to market its new rapid immunossay called QuickVue One-Step Fecal Occult Blood Test (FOB). This...

Phase I pilot trial for LuVax announced. (therapeutic vaccine for small cell lung cancer) (ImClone Systems Inc.)
March 1, 1993... ImClone Systems Incorporated, New York, New York, announced the initiation of the first human clinical trial for the treatment of small cell lung cancer using a proprietary therapeutic vaccine. The Phase I pilot trial is designed to...

Age weakens body's ability to fix sun-damaged cells. (Johns Hopkins University)
March 1, 1993... The ability of human cells to repair damage from sunlight exposure apparently steadily weakens with age and may provide a way to identify persons at greatest risk for skin cancer, researchers report. Researchers at Johns Hopkins University,...

Patients may be able to avoid unnecessary chemotherapy. (better laboratory testing of anti-cancer drugs) (California)
March 1, 1993... The ability to predict future applications of new chemotherapy drugs without the necessity of taking them through costly and painful clinical trials in patients may be near, according to an article published in the February 1993 edition of the...

Reversing multidrug resistance. (with MRK-16 and cyclosporine) (Japan)
March 1, 1993... The combination of MRK-16, a monoclonal antibody against P-glycoprotein, and the immunosuppressive agent cyclosporine synergistically enhanced the accumulation and antitumor effects of vincristine and doxorubicin in drug-resistant cancer cells,...

No CAP for early NSCLC. (cyclophosphamide, doxorubicin, cisplatin; non-small cell lung cancer) (University of Toronto)
March 1, 1993... A study found no advantage to adjuvant therapy with cyclophosphamide, doxorubicin and cisplatin (CAP) following surgery in patients with stage I non-small-cell lung cancer (NSCLC). The investigators, reporting in the February 17, 1993 issue...

Oral cancer diagnostic aid in use. (OraScan) (United Kingdom)
March 1, 1993... The first diagnostic aid for oral cancer has already found use in the United Kingdom's premier dental hospital - even as regulatory approvals are being finalized in the United Kingdom and the U.S. OraScan, a product of Zila Pharmaceuticals...

Yew harvesting in limbo in national forests. (Oregon)
March 1, 1993... Harvesting of Pacific yew trees is in limbo across the Northwest's national forests now that Bristol-Myers Squibb Inc. has decided it has all the bark it needs to make the anticancer drug Taxol, a Forest Service official said. "Things are...

Cooperative Breast Cancer Tissue Registry. (National Cancer Institute research grant announcement) (Research Report)
March 1, 1993... "Letter of Intent Receipt Date: March 15, 1993 Application Receipt Date: April 29, 1993. Purpose: The Cancer Diagnosis Branch of the Division of Cancer Biology, Diagnosis and Centers at the U.S. National Cancer Institute (NCI) invites...

Treatment of pituitary tumors with boron neutron capture therapy. (Research Report)
March 1, 1993... According to an abstract submitted by the authors to a Joint Meeting of the Western Section American Federation for Clinical Research, Western Society for Clinical investigation, Western Society for Pediatric Research, Western Student Medical...

The promise and the reality of viral vaccines against cancer. (Research Report)
March 1, 1993... According to an abstract presented by the author to the Specific Immunotherapy of Cancer Vaccines Conference, held January 21-24, 1993, in Washington, D.C., "Viruses cause about 10-15% of neoplasia in human beings. Both DNA and RNA viruses are...

Tumor immunology - an overview. (Research Report)
March 1, 1993... According to an abstract presented by the authors to the Specific Immunotherapy of Cancer Vaccines Conference, held January 21-24, 1993, in Washington, D.C., "Most chemically-induced animal tumors have individually unique antigens while...

Human tumor antigens relevant for vaccine construction: an overview. (Research Report)
March 1, 1993... According to an abstract presented by the author to the Specific Immunotherapy of Cancer Vaccines Conference, held January 21-24, 1993, in Washington, D.C., "Successful construction of anticancer vaccines requires thorough characterization of...

Tumor antigens known to be immunogenic in man. (Research Report)
March 1, 1993... According to an abstract presented by the author to the Specific Immunotherapy of Cancer Vaccines Conference, held January 21-24, 1993, in Washington, D.C., "A limited number of tumor cell components have been shown to be immunogenic in cancer...

Melanoma polyvalent vaccine improves survival. (Research Report)
March 1, 1993... According to an abstract presented by the author to the Specific Immunotherapy of Cancer Vaccines Conference, held January 21-24, 1993, in Washington, D.C., "A whole-cell vaccine developed from three highly antigenic human melanoma cell lines...

Rationale for, and results of, autologous tumor cell vaccine combined with immunomodulators. (Research Report)
March 1, 1993... According to an abstract presented by the authors to the Specific Immunotherapy of Cancer Vaccines Conference, held January 21-24, 1993, in Washington, D.C., "We are studying the clinical and immunological effects of an autologous melanoma...

How do nurses assess the information received by breast cancer patients? (Periodical Report)
March 1, 1993... "HOW DO NURSES ASSESS THE INFORMATION RECEIVED BY BREAST CANCER PATIENTS?," JOURNAL OF ADVANCED NURSING, 1993; 18:64-68. Although information is critical to relieving the uncertainty of patients in ahealthcare system, nurses regard...

Coping styles in identifiers and nonidentifiers of a breast lump as a problem. (Periodical Report)
March 1, 1993... "COPING STYLES IN IDENTIFIERS AND NONIDENTIFIERS OF A BREAST LUMP AS A PROBLEM," PSYCHOSOMATICS, JANUARY-FEBRUARY 1993;34(1):53-60. A large proportion of a sample of women referred to a clinic because of a lump in the breast did not...

Nutrition counseling for breast cancer patients. (Periodical Report)
March 1, 1993... Mastectomy patients are prime targets for nutrition counseling and such counseling should begin while they are still inpatients, say the authors of an Ohio State study. Studies have shown that obese women with breast cancer tend to have...

Early detection of relapse after bone-marrow transplantation in patients with chronic myelogenous leukemia. (Periodical Report)
March 1, 1993... Monitoring by quantiative polymerase chain reaction (PCR) of residual leukemic cells in the period following allogeneic bone-marrow transplant (BMT) of patients with chronic myelogenous leukemia (CML) can allow early detection of relapse, say...

Expansion of the epithelial cell proliferative compartment and frequency of adenomatous polyps in the colon correlate with the strength of family history of colorectal cancer. (Periodical Report)
March 1, 1993... Parallel abnormalities of colonic epithelial cell proliferation and neoplasia in subjects with a family history of colorectal cancer, both of which were more marked with increasing strength of family hisory, provides further evidence of...

Scientists attack brain cancers with herpes gene. (University of Iowa)
March 8, 1993... Under an experimental therapy approved by a federal committee, scientists willattack brain cancers by infecting tumor cells with a herpes gene and then killing the cancer with a herpes drug. The experimental therapy, proposed by medical...

Treatment injects cancer-fighting drugs directly into tumor. (chemoembolization) (Society of Cardiovascular and Interventional Radiology)
March 8, 1993... A combination of cancer-fighting drugs injected directly into tumors is improving survival for some patients with inoperable liver cancers. Results with the technique, including its use in young children, were reported March 1, 1993, at...

Scientists isolate new antibiotics from a shark. (squalamine) (Pennsylvania)
March 8, 1993... Proceedings of the National Academy of Sciences reported in its February 1993 issue the discovery of squalamine, a new steroid-like antibiotic substance identified in the dogfish shark. The discovery was made by Dr. Michael Zasloff,...

Scientists ask for British permission to try out gene therapy on skin cancer. (England)
March 8, 1993... Scientists said they would ask the British government for permission to conduct gene therapy trials on people suffering from the most serious form of skin cancer. Experts at the Imperial Cancer Research Fund (ICRF) already have tested in...

Hearing examines pricing of cancer drugs. (U.S. House of Representatives)
March 8, 1993... Using the anticancer drug paclitaxel (Taxol) as a case study, Representative Ron Wyden (Democrat-Oregon) challenged the U.S. government to develop a comprehensive drug pricing policy "so that our citizens don't have to choose between getting...

Two studies show anti-tumor effects of Taxol in advanced NSCLC. (non-small cell lung cancer) (New York/Texas)
March 8, 1993... As reported in the March 3, 1993, issue of the Journal of the National Cancer Institute, two new human studies of Taxol show rates of response at least as good as existing single drug treatments for advanced nonsmall cell lung cancer (NSCLC),...

Company to begin human trials on new anticancer drug. (DS-4152 angiogenesis inhibitor) (Daiichi Pharmaceutical Corporation)
March 8, 1993... Daiichi Pharmaceutical Corporation of Fort Lee, New Jersey, announced the filing of an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) for DS-4152, a compound in a new class of anticancer agents known...

Abortion pill company eases stand on marketing in U.S. (Roussel-Uclaf) (France)
March 8, 1993... The president of the French company that manufactures the abortion pill RU-486 says he is willing to work out an agreement to market the drug in the U.S., the New York Times reported. In the past, Roussel-Uclaf had refused to seek approval...

No link found between breast cancer, body shape. (Memorial Sloan-Kettering Cancer Center)
March 8, 1993... A new study contradicts the notion that body shape affects a woman's risk for breast cancer. Instead of worrying over pear- or apple-shaped bodies, women should focus more on controlling their amount of body fat, researchers from Memorial...

Group says to screen only women age 50 and older. (mammography) (European Society of Mastology)
March 8, 1993... Seventeen European breast cancer experts meeting in Paris, France, in February 1993 agreed that women should only be screened with mammography above age 50 and that screening for younger women should only be done as part of a research study,...

Summary study finds no benefit of mammography for younger women. (New Zealand)
March 8, 1993... Mammography screening for breast cancer offers no long-term survival benefit for women in their 40s, but the test does save lives among women age 50 and older, according to a study that analyzed research in the United States, Canada and Europe....

Mammograms reportedly no benefit to women under 50. (Maryland)
March 8, 1993... Women in their 40s do not appear to benefit from mammograms, according to a study that found those who undergo the tests have the same death rate from breast cancer as those who do not. The findings, disclosed at a February 25, 1993,...

New breast cancer test. (bio-marker based on breast rhythms and hormonal changes) (Ohio)
March 8, 1993... A Dayton, Ohio company believes it has discovered a new bio-marker for breast cancer that will allow doctors to help stop the disease before it even starts. "We think we've found a relationship between circadian rhythm of the breast and...

Studies to prevent cancer recurrence begin. (testing 13-cis retinoic acid) (St. Luke's Episcopal Hospital)
March 8, 1993... Two new cancer studies under way at St. Luke's Episcopal Hospital in Houston, Texas, are targeted at preventing cancer recurrence in patients who have previously been treated for malignant tumors. Study participants will include patients who...

Treatment recommendations for ovarian cancer not always followed. (Illinois)
March 8, 1993... Many physicians treating women with ovarian carcinoma may not be classifying the cancer with the recommended method; however, a majority of physicians are treating their patients with later state cancer appropriately, according to a study...

Active specific immunotherapy of melanoma: rationale for the use of allogeneic lysates. (Research Report)
March 8, 1993... According to an abstract presented by the author to the Specific Immunotherapy of Cancer Vaccines Conference, held January 21-24, 1993, in Washington, D.C., "Since 1985, we have used mechanical lysates from 2 melanoma cell lines and the...

T-cell immunity to cancer specific oncogenic proteins. (Research Report)
March 8, 1993... According to an abstract presented by the authors to the Conference on Specific Immunotherapy of Cancer Vaccines, held January 21-24, 1993, in Washington, D.C., "Malignant transformation results from a series of definable DNA mutations many of...

Human high molecular weight-melanoma associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic (Anti-Id) mAb MK2-23 - modulation of the immunogenicity in patients with advanced melanoma. (Research Report)
March 8, 1993... According to an abstract presented by the authors to the Conference on Specific Immunotherapy of Cancer Vaccines, held January 21-24, 1993, in Washington, D.C., "Fifty-six patients with advanced melanoma were immunized with mAb MK2-23 with and...

Gene therapy of cancer. (Research Report)
March 8, 1993... According to an abstract presented by the author to the Conference on Specific Immunotherapy of Cancer Vaccines, held January 21-24, 1993, in Washington, D.C., "Attempts are underway to develop new immunotherapeutic approaches to the treatment...

Tumor mucin specific immunity: expression vector based vaccines. (Research Report)
March 8, 1993... According to an abstract presented by the author to the Conference on Specific Immunotherapy of Cancer Vaccines, held January 21-24, 1993, in Washington, D.C., "The importance of mucins as tumor-associated antigens has recently been increased...

Epitope selection and design of synthetic vaccines. (Research Report)
March 8, 1993... According to an abstract presented by the author to the Conference on Specific Immunotherapy of Cancer Vaccines, held January 21-24, 1993, in Washington, D.C., "Recent advances in the understanding of antigen processing and presentation...

New adjuvants for the next generation of vaccines. (Research Report)
March 8, 1993... According to an abstract presented by the authors to the Conference on Specific Immunotherapy of Cancer Vaccines, held January 21-24, 1993, in Washington, D.C., "Poor immunogenicity of many genetically engineered antigens has engendered a need...

Conjugate vaccines with synthetic tumor-associated antigens. (Research Report)
March 8, 1993... According to an abstract presented by the authors to the Conference on Specific Immunotherapy of Cancer Vaccines, held January 21-24, 1993, in Washington, D.C., "Carcinoma cells bear cell surface mucins which 'mask' anticancer effector...

Characterization of autologous tumor vaccines prepared from colon and renal cell carcinomas (RCC) and melanomas. (Research Report)
March 8, 1993... According to an abstract presented by the authors to the Conference on Specific Immunotherapy of Cancer Vaccines, held January 21-24, 1993, in Washington, D.C., "Theoretically, for an autologous tumor-cell vaccine to be efficacious the vaccine...

Inherited factors and environmental exposures in cancer risk. (Periodical Report)
March 8, 1993... Cancer is a multistage disease, and the accuracy of cancer risk assessments is undermined by a reliance on mathematical models that do not incorporate the stages of carcinogenesis and interindividual variation, says the author of this study....

Clinical significance of diminutive polyps of the rectum and sigmoid colon. (Periodical Report)
March 8, 1993... Total colonic evaluation should be considered in all patients with a polyp in the rectum or sigmoid colon, regardless of the polyp's size or histologic type, say the authors of this retrospective review. The majority of polyps revealed in...

Malignant melanoma in children. (Periodical Report)
March 8, 1993... Excision of small congenital nevi during the first decade of life is an unreasonable option since such nevi rarely undergo malignant change before puberty, say the authors of this study. Approximately 2 percent of melanomas occur in...

Quality of life measurement in breast cancer. (Periodical Report)
March 8, 1993... Information gained from an assessment of the quality of life variables that come into play in the case of breast cancer can allow clinical trialists to evaluate different treatments, help the doctor and patient to determine the most appropriate...

Mandibular osteomas in sporadic colorectal carcinoma: a genetic marker. (Periodical Report)
March 8, 1993... Mandibular osteomas are probable genetic markers of the development of sporadic colorectal cancer, say the authors of this Danish study. The etiology of colorectal cancer is unknown, the authors note, save for the dominant hereditary...

Quality of life issues in lung cancer: new symptom management strategies. (Periodical Report)
March 8, 1993... Healthcare professionals play a vital role in the identification and management of the complications of cancer treatment and can thereby enhance the quality of life of cancer patients, according to this study from the University of Colorado...

Risk factors for screen-detected breast cancer. (Periodical Report)
March 8, 1993... Late age at first childbirth, breast cancer in the mother and early age at menarche were found to be risk factors for breast cancer in this Finnish study, but they appear to be of limited value in targeting a population for screening. H....

Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the clinical screening group of the European Organization for Research and Treatment of Cancer (EORTC). (Periodical Report)
March 8, 1993... The role of pirarubicin (THP), a new semi-synthetic anthracyclin, in the treatment of gynecological cancers merits further study, say the authors of this study from the European Organization for Research and Treatment of Cancer. THP acts...

Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. (Periodical Report)
March 8, 1993... Hodgkin's lymphoma should be included on the list of diseases associated with the loss of intrahepatic bile ducts, write the authors of this English study; and the possibility of a vanishing bile duct syndrome should be considered in the...

Pneumocystis carinii pneumonia in patients with cancer. (Periodical Report)
March 8, 1993... Prophylaxis for Pneumocystis carinii pneumonia (PCP) should be considered after an initial episode in all cancer patients who are and will remain immunosuppressed, say the authors of this Belgian study. 1. Varthalitis and colleagues...

Pulmonary morbidity 10-18 years after irradiation for Hodgkin's disease. (Periodical Report)
March 8, 1993... A small but significant impairment in pulmonary function exists in patients irradiated for Hodgkin's lymphoma (Hodgkin's disease), write the authors of this study from the Netherlands. Elly Hassink and colleagues performed pulmonary...

Doctors launch tests of taxol against soft tissue sarcoma. (University of Florida)
March 15, 1993... University of Florida Taxol, a potent cancer-fighting chemical extracted from yew trees, now will be tested against soft tissue sarcoma at the University of Florida (UF) Health Science Center, Gainesville, Florida. Patients with...

Test for colon cancer found inaccurate. (Hemoccult) (Mayo Clinic)
March 15, 1993... Mayo Clinic The most widely used screening test for colon cancer is practically worthless, Mayo Clinic researchers reported in the March 10, 1993, issue of the Journal of the American Medical Association. A three-year study of...

Researchers find way to target natural killer cells against colon cancer. (lymphokine-activated killer cells) (Massachusetts)
March 15, 1993... Massachusetts Special antibodies can turn human immune cells into killers that track down and destroy colon cancer cells, researchers reported. In a study published in the March 5, 1993, issue of the journal Science, Dr. Hiroshi...

Sea urchins may offer clues to fertilization and cancer. (University of New York, Stony Brook)
March 15, 1993... University of New York, Stony Brook University of New York, Stony Brook, scientists have cloned the gene for fertilization in sea urchins - an important feat that one day may offer clues to a protein that plays a key role in human...

Cladribine approved for treatment of hairy cell leukemia. (U.S. Food and Drug Administration)
March 15, 1993... U.S. FDA The U.S. Food and Drug Administration (FDA) announced approval of a one-treatment intravenous drug for hairy cell leukemia, a rare, often fatal cancer of the blood and bone marrow. The drug, cladribine, with the trade name...

Study links radiation to childhood leukemia. (children of nuclear industry workers found to be at risk) (United Kingdom)
March 15, 1993... United Kingdom A study published March 5, 1993, in the British Medical Journal draws a connection between children's leukemia and a parent with a job in the nuclear industry. The study said children of such workers run a risk of...

Researchers use light to provide window on living tissue. (Stanford University Medical Center)
March 15, 1993... Stanford University Medical Center A new method for imaging the body that uses ordinary light was reported by researchers at Stanford University Medical School, Stanford, California, in the March 5, 1993, issue of Science. Compared to...

Leakage from silicone breast implants is accurately detected by new technique. (endoscopic inspection) (Ohio)
March 15, 1993... Ohio For women with silicone-filled breast implants who are concerned about silicone leakage, endoscopic inspection provides a definitive answer, according to an article in Plastic and Reconstructive Surgery Journal. Dr. Richard...

Company announces heightened interest in advanced breast examination technologies. (LINTRO-SCAN and MAMMO-SCAN) (Lintronics Technologies Inc.)
March 15, 1993... Lintronics Technologies Inc. D. Jerry Diamond, chairman/CEO of EVRO Financial Corp., announced that its subsidiary, Lintronics Technologies Inc., has experienced a heightened interest in its two advanced breast examination technologies,...

Potential new class of drugs shows promise for treatment of complications of cancer. (growth hormone antagonists) (Ohio University Edison Animal Biotechnology Center)
March 15, 1993... Ohio A new class of drugs that counteract the effects of growth hormone has the potential to treat several important diseases caused by abnormal cell proliferation and growth, according to scientists at the Ohio University Edison Animal...

Advisory committee recommends approval of injectable Zyloprim as adjunct to cancer chemotherapies. (allopurinol sodium) (U.S. Food and Drug Administration Oncologic Drugs Advisory Committee)
March 15, 1993... U.S. FDA The U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee has unanimously recommended that the FDA approve an injectable form of the drug Zyloprim (allopurinol sodium) as a treatment for cancer patients...

Panelists identify growing dilemma in cancer patient care as Clinton administration develops healthcare reform. (Hoffman-LaRoche Inc. and American Cancer Society panel discussion)
March 15, 1993... Hoffmann-La Roche Inc. In any discussion about national healthcare reform, the special needs of the cancer patient must be a top priority, according to a panel of cancer specialists and advocates assembled in Washington, D.C., by the...

Nicotine inhaler increases success rates for smoking cessation. (Denmark)
March 15, 1993... Denmark Testing of a new nicotine inhaler system significantly increased success rates among a group of smokers trying to quit the habit, compared to smokers using a placebo inhaler, according to a study published in the March 10, 1993,...

Anti-collagen antibodies are present in women with silicone breast implants. (Research Report)
March 15, 1993... AUTHORS: S.S. Teuber(1), M.J. Rowley(2) and M.E. Gershwin(1). (1)Davis, California; (2)Clayton, Victoria, Australia. According to an abstract presented by the authors to the Fiftieth Anniversary of the American Academy of Allergy and...

Second-look laparotomy (SLL) in ovarian germ cell tumors: the Gynecologic Oncology Group (GOG) experience. (Research Report)
March 15, 1993... AUTHORS: S. Williams, J. Blessing, P. DiSaia, F. Major and H. Ball. Gynecologic Oncology Group, Philadelphia, Pennsylvania. According to an abstract submitted by the authors to the 24th Annual Meeting of the Society of Gynecologic...